Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.81 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | CTNNB1 | P35222 | 6/20 | 0.64 |
| ▸ | WNT3A | P56704 | 6/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29639737 | 1.00 | ATM (0.81) | ATMMEN1KMT2ACTNNB1WNT3A | |
| SCHEMBL1092875 | 0.89 | ATM (1.00) | ATMCTNNB1WNT3AALDH1A1HPGD | |
| SCHEMBL16369471 | 0.88 | ATM (0.63) | ATMMEN1KMT2ACTNNB1WNT3A | |
| SCHEMBL31490470 | 0.86 | HPGD (0.82) | ATMMEN1KMT2ACTNNB1WNT3A | |
| SCHEMBL14144501 | 0.86 | ATM (0.87) | ATMKMT2ACTNNB1WNT3AALDH1A1 | |
| SCHEMBL3924051 | 0.86 | HPGD (0.82) | ATMMEN1KMT2ACTNNB1WNT3A | |
| SCHEMBL29458253 | 0.85 | MEN1 (0.76) | ATMMEN1KMT2ACTNNB1WNT3A | |
| SCHEMBL2237626 | 0.85 | MEN1 (0.76) | ATMMEN1KMT2ACTNNB1WNT3A | |
| SCHEMBL26940453 | 0.85 | ATM (0.90) | ATMKMT2ACTNNB1WNT3AALDH1A1 | |
| SCHEMBL6486626 | 0.84 | CTNNB1 (0.66) | ATMMEN1KMT2ACTNNB1WNT3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138964-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | claimed |
| EP-4605385-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | Transcend Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| EP-4284789-B1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA SPA (IT) | 2025-04-16 | — | — | EP | claimed |
| US-20240425471-A1 | Process For The Preparation Of 3,4-Methylenedioxypropiophenone | ENDURA S.P.A. (IT) | 2024-12-26 | — | — | US | claimed |
| US-20240374558-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | US | claimed |
| US-20240327372-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-10-03 | — | — | US | claimed |
| WO-2024086218-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | claimed |
| CN-113490659-B | Improved and economically viable process for preparing aryl ketones | 安西娅芳香剂私人有限公司 | 2024-03-29 | — | — | CN | claimed |
| EP-4284789-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.p.A. (IT) | 2023-12-06 | — | — | EP | claimed |
| CN-117015533-A | Method for preparing 3, 4-methylenedioxypropiophenone | 恩德拉股份公司 | 2023-11-07 | — | — | CN | claimed |
| US-11518727-B2 | Commercially viable process for preparation of aryl ketones | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2022-12-06 | — | — | US | claimed |
| WO-2022162223-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | claimed |
| WO-2022161628-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | claimed |
| CN-114599355-A | Method for treating psychological and cerebral diseases | 马里兰大学巴尔的摩分校 | 2022-06-07 | — | — | CN | claimed |
| US-20220169588-A1 | AN IMPROVED AND COMMERCIALLY VIABLE PROCESS FOR PREPARATION OF ARYL KETONES | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2022-06-02 | — | — | US | claimed |
| CN-113490659-A | Improved and economically viable process for preparing aryl ketones | 安西娅芳香剂私人有限公司 | 2021-10-08 | — | — | CN | claimed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | claimed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | claimed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | claimed |
| JP-61085379-A | — | — | None | — | — | JP | disclosed |
| US-20260138964-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260138964-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4731211-A1 | ALLYL- AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Definium Therapeutics US, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20250312309-A1 | ALLYL-AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Mind Medicine, Inc. (US) | 2025-10-09 | — | — | US | disclosed |
| EP-4605385-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | Transcend Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-4605385-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | Transcend Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| US-20250179042-A1 | USE OF DEUTERATED EMPATHOGENS AS THERAPEUTIC AGENTS | ALEXANDER SHULGIN RES INSTITUTE INC (US) | 2025-06-05 | — | — | US | disclosed |
| EP-4284789-B1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA SPA (IT) | 2025-04-16 | — | — | EP | disclosed |
| EP-4284789-B1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA SPA (IT) | 2025-04-16 | — | — | EP | disclosed |
| EP-4284789-C0 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA SPA (IT) | 2025-04-16 | — | — | EP | disclosed |
| US-12234216-B2 | Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof | TERRAN BIOSCIENCES INC. (US) | 2025-02-25 | — | — | US | disclosed |
| US-12221428-B2 | Use of deuterated empathogens as therapeutic agents | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2025-02-11 | — | — | US | disclosed |
| WO-2024263978-A1 | ALLYL- AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Mind Medicine, Inc. (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240425471-A1 | Process For The Preparation Of 3,4-Methylenedioxypropiophenone | ENDURA S.P.A. (IT) | 2024-12-26 | — | — | US | disclosed |
| US-20240425471-A1 | Process For The Preparation Of 3,4-Methylenedioxypropiophenone | ENDURA S.P.A. (IT) | 2024-12-26 | — | — | US | disclosed |
| US-20240425471-A1 | Process For The Preparation Of 3,4-Methylenedioxypropiophenone | ENDURA S.P.A. (IT) | 2024-12-26 | — | — | US | disclosed |
| US-20240374558-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | US | disclosed |
| US-20240374558-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | US | disclosed |
| US-20240351993-A1 | Use of Deuterated Empathogens as Therapeutic Agents | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. | 2024-10-24 | — | — | US | disclosed |
| US-20240327372-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-10-03 | — | — | US | disclosed |
| US-20240327372-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-10-03 | — | — | US | disclosed |
| US-20240294488-A1 | ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC (US) | 2024-09-05 | — | — | US | disclosed |
| US-12043605-B2 | Deuterated empathogens | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-12043605-B2 | Deuterated empathogens | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-12043605-B2 | Deuterated empathogens | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| EP-4392028-A1 | DEUTERATED EMPATHOGENS | Alexander Shulgin Research Institute, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024086218-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024086218-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | TRANSCEND THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| US-20240124411-A1 | Deuterated Empathogens | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. | 2024-04-18 | — | — | US | disclosed |
| CN-113490659-B | Improved and economically viable process for preparing aryl ketones | 安西娅芳香剂私人有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-4284789-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.p.A. (IT) | 2023-12-06 | — | — | EP | disclosed |
| EP-4284789-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.p.A. (IT) | 2023-12-06 | — | — | EP | disclosed |
| EP-4284789-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.p.A. (IT) | 2023-12-06 | — | — | EP | disclosed |
| CN-117015533-A | Method for preparing 3, 4-methylenedioxypropiophenone | 恩德拉股份公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-117015533-A | Method for preparing 3, 4-methylenedioxypropiophenone | 恩德拉股份公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-117015533-A | Method for preparing 3, 4-methylenedioxypropiophenone | 恩德拉股份公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20230212152-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Pardes Biosciences, Inc. | 2023-07-06 | — | — | US | disclosed |
| US-20230192642-A1 | ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230192642-A1 | ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230192642-A1 | ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. | 2023-06-22 | — | — | US | disclosed |
| US-11680062-B2 | 3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease | NORTHWEST A & F UNIVERSITY (CN) | 2023-06-20 | — | — | US | disclosed |
| US-20230159503-A1 | 3,4-METHYLENEDIOXYPHENYLIMIDAZOLYLETHANONEXIME ETHER DERIVATIVE, PREPARATION METHOD AND USE THEREOF, AND DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | NORTHWEST A & F UNIVERSITY (CN) | 2023-05-25 | — | — | US | disclosed |
| WO-2023081403-A1 | ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081403-A1 | ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023028091-A1 | DEUTERATED EMPATHOGENS | ALEXANDER SHULGIN RESEARCH INSTITUTE (US) | 2023-03-02 | — | — | WO | disclosed |
| US-11518727-B2 | Commercially viable process for preparation of aryl ketones | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2022-12-06 | — | — | US | disclosed |
| US-11518727-B2 | Commercially viable process for preparation of aryl ketones | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2022-12-06 | — | — | US | disclosed |
| WO-2022162223-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | disclosed |
| WO-2022162223-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | disclosed |
| WO-2022162223-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | disclosed |
| WO-2022161628-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | disclosed |
| WO-2022161628-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | disclosed |
| WO-2022161628-A1 | PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYPROPIOPHENONE | ENDURA S.P.A. (IT) | 2022-08-04 | — | — | WO | disclosed |
| CN-114599355-A | Method for treating psychological and cerebral diseases | 马里兰大学巴尔的摩分校 | 2022-06-07 | — | — | CN | disclosed |
| US-20220169588-A1 | AN IMPROVED AND COMMERCIALLY VIABLE PROCESS FOR PREPARATION OF ARYL KETONES | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2022-06-02 | — | — | US | disclosed |
| US-20220169588-A1 | AN IMPROVED AND COMMERCIALLY VIABLE PROCESS FOR PREPARATION OF ARYL KETONES | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2022-06-02 | — | — | US | disclosed |
| WO-2022097622-A1 | ODOR ANALYZING DEVICE, ODOR ANALYSIS METHOD, AND ODOR ANALYSIS PROGRAM | 株式会社レボーン | 2022-05-12 | — | — | WO | disclosed |
| EP-3931173-A1 | AN IMPROVED AND COMMERCIALLY VIABLE PROCESS FOR PREPARATION OF ARYL KETONES | Anthea Aromatics Private Limited (IN) | 2022-01-05 | — | — | EP | disclosed |
| CN-113490659-A | Improved and economically viable process for preparing aryl ketones | 安西娅芳香剂私人有限公司 | 2021-10-08 | — | — | CN | disclosed |
| WO-2021161083-A1 | AN EFFICIENT PROCESS FOR PREPARATION OF ACYL DERIVATIVES OF ALKYLENEDIOXYBENZENES | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021161083-A1 | AN EFFICIENT PROCESS FOR PREPARATION OF ACYL DERIVATIVES OF ALKYLENEDIOXYBENZENES | ANTHEA AROMATICS PRIVATE LIMITED (IN) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021085321-A1 | RESIN COMPOSITION, RESIN SHEET, CURED FILM, METHOD FOR MANUFACTURING CURED FILM, SEMICONDUCTOR DEVICE, ORGANIC EL DISPLAY DEVICE, AND DISPLAY DEVICE | 東レ株式会社 | 2021-05-06 | — | — | WO | disclosed |
| EP-3448843-B1 | ARYL BETA DIKETONES AND THEIR USE A ODORANTS | GIVAUDAN SA (CH) | 2021-02-24 | — | — | EP | disclosed |
| US-10577298-B2 | Aryl beta diketones and their use as odorants | GIVAUDAN S.A. (CH) | 2020-03-03 | — | — | US | disclosed |
| US-20190127305-A1 | ARYL BETA DIKETONES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2019-05-02 | — | — | US | disclosed |
| US-10246471-B2 | ETP derivatives | CITY OF HOPE (US) | 2019-04-02 | — | — | US | disclosed |
| US-20180179151-A1 | SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF | UNIVERSITY OF TSUKUBA (JP) | 2018-06-28 | — | — | US | disclosed |
| CN-104803927-B | Chalcone analog of the base containing 2 methyl, 4 oxoquinazolin 6 and its production and use | 首都师范大学 | 2017-11-07 | — | — | CN | disclosed |
| WO-2017186846-A1 | ARYL BETA DIKETONES AND THEIR USE A ODORANTS | GIVAUDAN SA (CH) | 2017-11-02 | — | — | WO | disclosed |
| WO-2016172631-A2 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-10-27 | — | — | WO | disclosed |
| CN-104803927-A | Chalcone analogue containing 2-methyl-4-oxo-quinazoline-6-base, and preparation method and application thereof | UNIV CAPITAL NORMAL | 2015-07-29 | — | — | CN | disclosed |
| CN-104004128-A | Photosensitive copolymer, photoresist comprising the copolymer, and method of forming an electronic device | ROHM & HAAS ELECT MAT | 2014-08-27 | — | — | CN | disclosed |
| US-20130196978-A1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-08-01 | — | — | US | disclosed |
| CN-102438991-A | Carbinol compounds having a heterocyclic linker | KOWA CO | 2012-05-02 | — | — | CN | disclosed |
| US-8153634-B2 | Carbinol derivatives having cyclic linker | KOWA COMPANY, LTD. (JP) | 2012-04-10 | — | — | US | disclosed |
| CN-102105452-A | Substituted carbinol compound having cyclic linker | KOWA CO | 2011-06-22 | — | — | CN | disclosed |
| EP-2281817-A1 | SUBSTITUTED CARBINOL COMPOUND HAVING CYCLIC LINKER | Kowa Company, Ltd. (JP) | 2011-02-09 | — | — | EP | disclosed |
| US-20100048610-A1 | CARBINOL DERIVATIVES HAVING CYCLIC LINKER | KOWA COMPANY, LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7645781-B2 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | PFIZER INC (US) | 2010-01-12 | — | — | US | disclosed |
| EP-1304324-B1 | SEROTONIN REUPTAKE INHIBITORS | DAINIPPON SUMITOMO PHARMA CO (JP) | 2007-10-03 | — | — | EP | disclosed |
| US-20070015801-A1 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | THOMAS RICHARD C | 2007-01-18 | — | — | US | disclosed |
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| EP-1638909-A2 | PROCESS FOR PREPARING ALKOXY- AND ARYLOXY-PHENOLS | ENDURA S.p.A. (IT) | 2006-03-29 | — | — | EP | disclosed |
| WO-2004092106-A2 | PROCESS FOR PREPARING ALKOXY- AND ARYLOXY-PHENOLS | ENDURA S.P.A. (IT) | 2004-10-28 | — | — | WO | disclosed |
| EP-1421071-A2 | SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS | NOVO NORDISK A/S (DK) | 2004-05-26 | — | — | EP | disclosed |
| EP-1140894-B1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA SPA (IT) | 2003-12-17 | — | — | EP | disclosed |
| US-6583154-B1 | Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines | AMGEN INC. | 2003-06-24 | — | — | US | disclosed |
| WO-2003004480-A2 | SUBSTITUTED PIPERAZINE AND DIAZEPANES AS HISTAMINE H3 RECEPTOR AGONISTS | NOVO NORDISK A/S (DK) | 2003-01-16 | — | — | WO | disclosed |
| US-6342613-B1 | REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE | ENDURA S.P.A. (IT) | 2002-01-29 | — | — | US | disclosed |
| EP-1140894-A1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA S.p.A. (IT) | 2001-10-10 | — | — | EP | disclosed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | disclosed |
| EP-1054887-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Amgen Inc. (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-2000040575-A1 | PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS | ENDURA S.P.A. (IT) | 2000-07-13 | — | — | WO | disclosed |
| WO-1999040091-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC. (US) | 1999-08-12 | — | — | WO | disclosed |
| WO-1996039133-A1 | NOVEL N-SUBSTITUTED-2-AMINO-3',4'-METHYLENE-DIOXYPROPIOPHENONES | NEUROBIOLOGICAL TECHNOLOGIES, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| EP-0589039-A1 | TRIPHENYLETHYLENE DERIVATIVE AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1994-03-30 | — | — | EP | disclosed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | disclosed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | disclosed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | disclosed |
| JP-S6185379-A | 3',4'-METHYLENEDIOXYPROPIOPHENONE DERIVATIVE AND CENTRAL MUSCULE RELAXANT CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT | TOKYO TANABE CO LTD | 1986-04-30 | — | — | JP | disclosed |
| EP-0163537-A1 | 1-Propanone derivatives and pharmaceutical compositions containing same | TOKYO TANABE COMPANY LIMITED (JP) | 1985-12-04 | — | — | EP | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3962415-A | Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer | AIRWICK INDUSTRIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
| US-3946040-A | JUVENILE HORMONE ACTIVITY, INSECTICIDES | HOFFMANN-LA ROCHE INC. (US) | 1976-03-23 | — | — | US | disclosed |
| JP-S06185379-A | — | — | 0001-01-01 | — | — | JP | disclosed |
| JP-S06185379-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (24 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10246471-B2 | ETP derivatives | ETV6, ETV1, ELP1 | ATM 1053/4885MEN1 3286/4885KMT2A 2611/4885 |
| US-20180179151-A1 | SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF | HCRTR2, HCRTR1, NPSR1 | ATM 4791/4885MEN1 2469/4885KMT2A 234/4885 |
| US-20230159503-A1 | 3,4-METHYLENEDIOXYPHENYLIMIDAZOLYLETHANONEXIME ETHER DERIVATIVE, PREPARATION METHOD AND USE THEREOF, AND DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | NOS3, CYP51A1, NOS1 | ATM 1051/4885MEN1 3755/4885KMT2A 1942/4885 |
| US-10577298-B2 | Aryl beta diketones and their use as odorants | CBR3, CBR1, CHRM3 | ATM 2800/4885MEN1 3913/4885KMT2A 627/4885 |
| US-20190127305-A1 | ARYL BETA DIKETONES AND THEIR USE AS ODORANTS | CBR3, CBR1, CHRM3 | ATM 2800/4885MEN1 3913/4885KMT2A 627/4885 |
| US-20130196978-A1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF | CHRM3, CHRM1, CHRNG | ATM 771/4885MEN1 4121/4885KMT2A 1874/4885 |
| US-20250179042-A1 | USE OF DEUTERATED EMPATHOGENS AS THERAPEUTIC AGENTS | SLC18A2, SLC6A3, GAP43 | ATM 4111/4885MEN1 2108/4885KMT2A 1902/4885 |
| US-12234216-B2 | Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof | PYGB, NR3C2, CYP11B1 | ATM 1490/4885MEN1 1408/4885KMT2A 1583/4885 |
| US-11518727-B2 | Commercially viable process for preparation of aryl ketones | CYP2B6, CYP1B1, CYP1A1 | ATM 1427/4885MEN1 4527/4885KMT2A 1373/4885 |
| US-20240327372-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | PNMT, COMT, CYP2C19 | ATM 2731/4885MEN1 1168/4885KMT2A 345/4885 |
| US-12043605-B2 | Deuterated empathogens | SLC18A2, SLC6A3, GAP43 | ATM 4263/4885MEN1 2182/4885KMT2A 1364/4885 |
| US-20230192642-A1 | ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | PYGB, NR3C2, CYP11B1 | ATM 1490/4885MEN1 1408/4885KMT2A 1583/4885 |
| US-20260138964-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | DMPK, CHKB, TTK | ATM 1666/4885MEN1 482/4885KMT2A 1247/4885 |
| US-11680062-B2 | 3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease | NOS3, CYP51A1, NOS1 | ATM 1051/4885MEN1 3755/4885KMT2A 1942/4885 |
| US-20100048610-A1 | CARBINOL DERIVATIVES HAVING CYCLIC LINKER | NR1H2, NR1H3, LDLR | ATM 2086/4885MEN1 3823/4885KMT2A 2383/4885 |
| US-12221428-B2 | Use of deuterated empathogens as therapeutic agents | SLC18A2, SLC6A3, GAP43 | ATM 4111/4885MEN1 2108/4885KMT2A 1902/4885 |
| US-20220169588-A1 | AN IMPROVED AND COMMERCIALLY VIABLE PROCESS FOR PREPARATION OF ARYL KETONES | CYP2B6, CYP1B1, CYP2E1 | ATM 1820/4885MEN1 4669/4885KMT2A 1341/4885 |
| US-20240294488-A1 | ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | CYP11B1, PYGB, CYP11B2 | ATM 1692/4885MEN1 1881/4885KMT2A 2206/4885 |
| US-20240351993-A1 | Use of Deuterated Empathogens as Therapeutic Agents | SLC18A2, SLC6A3, GAP43 | ATM 4111/4885MEN1 2108/4885KMT2A 1902/4885 |
| US-20070015801-A1 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | OXA1L, AADAC, MT-ND5 | ATM 4474/4885MEN1 3522/4885KMT2A 1273/4885 |
| US-20240425471-A1 | Process For The Preparation Of 3,4-Methylenedioxypropiophenone | PF4, FGB, PFN1 | ATM 4233/4885MEN1 4397/4885KMT2A 3450/4885 |
| US-20240124411-A1 | Deuterated Empathogens | SLC18A2, SLC6A3, GAP43 | ATM 4263/4885MEN1 2182/4885KMT2A 1364/4885 |
| US-20240374558-A1 | PREPARATION OF PHENETHYLAMINES AND CATHINONES AND STEREOISOMERS THEREOF AND PRECURSORS THEREOF | PNMT, COMT, CYP2C19 | ATM 2731/4885MEN1 1168/4885KMT2A 345/4885 |
| US-20230212152-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | CTRL, CTSL, CTSV | ATM 2654/4885MEN1 4306/4885KMT2A 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.